Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672100 · ClinicalTrials.gov registry record · NA
Initial Local Anesthetic Dose With Continuous Interscalene Analgesia
A NA study of Postoperative Pain, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 2
- Study locations
NCT00672100: Completed NA study of Postoperative Pain, sponsored by Corewell Health East.
NCT00672100 is a NA study of Postoperative Pain that has completed, run by Corewell Health East. The registered enrollment target is 36 participants, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672100, a NA study of Postoperative Pain, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 2
- Study locations
Study Summary
Objective: To determine a minimally effective initial local anesthetic bolus required to provide satisfactory analgesia using continuous brachial plexus infusion following arthroscopic shoulder surgery using a double-blind, randomized, study comparing 3 initial doses.
Primary Outcome
Pain was reported via NRS ranging from 0 (no pain) to 10 (worst pain imaginable)
Conditions Studied
Interventions
- DRUG Ropivacaine
Study Locations (2)
Michigan
- William Beaumont Hospital - Royal Oak
- William Beaumont Hospitals - Troy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT00672100 record still lists
NCT00672100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 232-participant average among 120 other Postoperative Pain trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine is the first listed.
NCT00672100 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00672100 about?
NCT00672100 is a clinical study titled "Initial Local Anesthetic Dose With Continuous Interscalene Analgesia". Objective: To determine a minimally effective initial local anesthetic bolus required to provide satisfactory analgesia using continuous brachial plexus infusion following arthroscopic shoulder surgery using a double-blind, randomized, study comparing 3 initial doses.
What is the current status of trial NCT00672100?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2009-01. Estimated completion is 2010-08.
What conditions does trial NCT00672100 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT00672100?
The interventions under investigation include: Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT00672100?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00672100 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00672100's enrollment target sits among peer trials
36 112th of 120 higher than 9 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Pain With Differing Insufflation Pressures During Laparoscopic Hysterectomy
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia